Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

134
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
134
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

71
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
71
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

180
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
180
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

115
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
115
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
70

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
Same author

[Development of a curriculum for a fellowship in pediatric anesthesiology in Germany].

Die Anaesthesiologie·2026
Same author

Mapping the network of persistent somatic symptoms across diseases: Cross-sectional and longitudinal analyses from the SOMACROSS research unit.

Journal of psychosomatic research·2026
Same author

Antigen-specific tolerance and control of autoimmunity effected by liver sinusoidal endothelial cells is unimpaired in liver fibrosis.

Frontiers in immunology·2026
Same author

Zeitschrift fur Gastroenterologie·2026
Same author

Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensus.

Hepatology (Baltimore, Md.)·2026
Same journal

Decoding fibrosis: Transcriptomic and clinical insights via AI-derived collagen deposition phenotypes in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease.

Hepatology (Baltimore, Md.)·2026
Same journal

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Candidate evaluation.

Hepatology (Baltimore, Md.)·2026
Same journal

H4K12 lactylation drives TREM2high macrophages differentiation in liver fibrosis.

Hepatology (Baltimore, Md.)·2026
Same journal

Good vibrations: Using VCTE to predict hepatic decompensation in MASLD.

Hepatology (Baltimore, Md.)·2026
Same journal

One size does not fit all: Global variability in noninvasive testing for MASLD.

Hepatology (Baltimore, Md.)·2026
See all related articles

Related Experiment Video

Updated: May 31, 2025

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
00:08

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

9.9K

PSC and colitis: A complex relationship.

Ludwig J Horst1, Jan Kempski1,2,3, Martine Walmsley4

  • 1I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hepatology (Baltimore, Md.)
|January 22, 2025
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis with underlying colitis (PSC-IBD) is a distinct inflammatory bowel disease (IBD) form. Understanding the complex gut-liver axis is crucial for developing effective PSC-IBD therapies.

Keywords:
ColitisGut-liver axisIBDPSCPSC-IBD

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.0K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.0K

Related Experiment Videos

Last Updated: May 31, 2025

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
00:08

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

9.9K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.0K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.0K

Area of Science:

  • Hepatology and Gastroenterology
  • Immunology
  • Microbiome Research

Background:

  • Primary sclerosing cholangitis (PSC) is a challenging liver disease with limited understanding of its pathogenesis and no causal therapies.
  • PSC-IBD is increasingly recognized as a distinct entity within inflammatory bowel disease (IBD), not merely an extraintestinal manifestation.
  • The liver and gut exhibit complex bidirectional influences, impacting disease progression and patient quality of life.

Purpose of the Study:

  • To review current knowledge on the gut-liver axis in PSC-IBD.
  • To offer new perspectives on risk stratification and treatment strategies for PSC-IBD.
  • To identify knowledge gaps and guide future clinical trials and therapeutic development for PSC-IBD.

Main Methods:

  • Literature review synthesizing current research on PSC-IBD.
  • Analysis of clinical, genetic, and microbiome data related to the gut-liver axis in PSC-IBD.
  • Identification of pathophysiological factors including genetic predisposition, microbiota changes, bile acid metabolism, and immune cell migration.

Main Results:

  • Evidence suggests PSC-IBD is a unique form of IBD, with molecular links to colitis in nearly all PSC patients.
  • The gut-liver axis in PSC-IBD involves complex interactions, where liver and gut pathologies can influence each other, sometimes in protective or ameliorating ways.
  • Suspected contributors to PSC-IBD pathogenesis include genetic factors, altered gut microbiota, and dysregulated bile acid metabolism.

Conclusions:

  • The gut-liver axis plays a critical role in the pathogenesis of PSC-IBD.
  • A deeper understanding of these complex interactions is essential for advancing risk stratification and treatment.
  • Future research should focus on elucidating these mechanisms to improve therapeutic outcomes for patients with PSC-IBD.